Lv1
20 积分 2024-09-25 加入
Immunomodulatory effects of CDK4/6 inhibitors
1个月前
已完结
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors
1个月前
已完结
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
1个月前
已完结
Three-dimensional structure of interleukin-2
1个月前
已关闭
Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours
6个月前
已完结
A tumor-targeted cytokine/antibody fusion protein to stimulate anti-cancer immunity
7个月前
已关闭
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
8个月前
已完结
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
8个月前
已完结
Making Progress Along the Challenging Road of Drug Development for Patients With EGFR Exon 20 Insertion–Positive Non–Small Cell Lung Cancer
8个月前
已完结
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
8个月前
已完结
皖公网安备34019202002308
